PharmaSGP Holding SE Cash Flow-to-Debt Ratio
PharmaSGP Holding SE cash flow-to-debt ratio. PharmaSGP Holding SE (PSG) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2025, meaning its operating cash flow of €4.22 Million could theoretically repay 0% of its total liabilities (€81.51 Million) in one year. Check PSG cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of PharmaSGP Holding SE (2014–2024)
Cash flow-to-debt ratio of PharmaSGP Holding SE from 2014 to 2024. Historical debt coverage capacity for PharmaSGP Holding SE across 10 annual periods. Check PSG total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
PharmaSGP Holding SE Cash Flow-to-Debt Ratio by Year (2014–2024)
PharmaSGP Holding SE cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for PharmaSGP Holding SE. For the full cash flow conversion analysis, see PharmaSGP Holding SE cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.30x | €24.88 Million | €82.31 Million | ▲ +3.9% |
| 2023 | 0.29x | €26.64 Million | €91.55 Million | ▲ +15.4% |
| 2022 | 0.25x | €24.71 Million | €98.01 Million | ▲ +91.7% |
| 2021 | 0.13x | €12.24 Million | €93.06 Million | ▼ -88.6% |
| 2020 | 1.15x | €15.46 Million | €13.44 Million | ▼ -46.8% |
| 2019 | 2.16x | €17.63 Million | €8.16 Million | ▲ +234.8% |
| 2017 | 0.65x | €14.25 Million | €22.09 Million | ▲ +308.7% |
| 2016 | 0.16x | €3.55 Million | €22.47 Million | ▼ -65.0% |
| 2015 | 0.45x | €10.59 Million | €23.46 Million | ▲ +68.0% |
| 2014 | 0.27x | €5.41 Million | €20.13 Million | — |